Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

Latest News

Merkel seeks EU's patience as Germany forms new government

Oct 20, 2017

BERLIN — German Chancellor Angela Merkel asked her European Union partners Friday for patience in discussing the bloc's future as she engages in what could be lengthy efforts to form a government. Germany's Sept. 24 election left Merkel trying to form a new coalition made up of her conservative Union bloc, the pro-business Free Democrats and the traditionally left-leaning Greens. The combination hasn't been tried before at the national level in Germany. Exploratory talks opened Wednesday and stepped up Friday, when representatives of the potential partners all met together for the first time. The discussions are scheduled through Nov. 2,...

Slovenia: Instagram-loving incumbent leads presidential race

Oct 20, 2017

LJUBLJANA, Slovenia — Slovenia, the Alpine home country of Melania Trump, is holding a presidential election Sunday that incumbent President Borut Pahor — a former fashion model, like the U.S. first lady — is favored to win. Eight other candidates are vying for the largely ceremonial, but still influential head of state post. Opinion polls show Pahor, a veteran politician who gave up modeling long ago, could win a majority of votes and avoid a runoff election two weeks later. Below is some background on the race being decided in nature-loving Slovenia: ___ A PRESIDENT WHO IS KING OF INSTAGRAM...

Kids, screens and parental guilt: Time to loosen up?

Oct 20, 2017

NEW YORK — Parents of small children have long been hearing about the perils of "screen time." And with more screens, and new technologies such as Amazon's Echo speaker, the message is getting louder. And while plenty of parents are feeling guilty about it, some experts say it might be time to relax a little. Go ahead and hand your kid a gadget now and then to cook dinner or get some work done. Not all kids can entertain themselves quietly, especially when they are young. Try that, and see how long it takes your toddler to start fishing a...

Malta captain mutes goal celebration after journalist slain

Oct 20, 2017

Malta captain Andre Schembri says the car bomb slaying of a Maltese investigative journalist prompted him not to exult after scoring an historic goal. Schembri's temporary equalizer for Cypriot club Apollon in a 3-1 loss to Italian side Atalanta in the Europa League on Thursday made him the first Maltese player to score in proper European competition — excluding qualifying. But instead of pumping his fist or leaping in joy over the achievement, Schembri hung his head as teammates mobbed him. Schembri wrote on Facebook on Friday, "Celebrating my goal didn't feel right after what happened in Malta this week."...

The Latest: Tillerson: Freeing Syria's Raqqa is 'milestone'

Oct 20, 2017

BEIRUT — The Latest on developments in Syria (all times local): 6:05 p.m. U.S. Secretary of State Rex Tillerson has congratulated the Syrian people and the U.S.-backed Syrian Democratic Forces on the liberation of the city of Raqqa from the Islamic State group. In a statement released on Friday, Tillerson says the United States is proud to lead the 73-member global coalition in the fight against IS. He says the coalition efforts has seen Islamic State's "so-called caliphate crumble across Iraq and Syria" but cautions that "our work is far from over." Tillerson says the "liberation of Raqqa is a...